Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments

Related Keywords

United States ,London ,City Of ,United Kingdom ,Kigali ,W09 ,Rwanda ,America ,Isabella Zinck ,Arzum Ustun ,Nicole Zinsli Somm ,Samir Shah ,Parag Mahanti ,Julie Masow ,Neil Henderson ,Sloan Simpson ,Paul Barasa ,Alina Levchuk ,Novartis Institute For Tropical Diseases ,Novartis Institutes For Biomedical Research ,Twitter ,World Health Organization ,Novartis Global Health Communications ,Novartis Us External Communications ,Novartis External Communications ,Saharan Africa Communications ,Novartis ,Exchange Commission ,Drugs For Neglected Diseases Initiative Dndi ,Wellcome ,Kigali Declaration ,Kigali Summit ,Commonwealth Heads ,Neglected Tropical Disease Roadmap ,Vas Narasimhan ,London Declaration ,Malaria Summit ,Novartis Institute ,Tropical Diseases ,Neglected Diseases Initiative ,Novartis Institutes ,Biomedical Research ,Malaria Report ,Investegate Announcements ,Investegate Company Announcements ,Ovartis Ag Chf0 50 Regd ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,